4.4.2008 - jazmp

More documents

Recommendations

Info

Javna agencija RS za zdravila in medicinske pripomočke SEZNAM CEN ZDRAVIL IN CEN ZDRAVIL NA DEBELO <strong>4.4.2008</strong> štev.: 61-22/2007-51 Delovna šifra Zaščiteno ime Proizvaj. cena Cena na Datum debelo veljavnosti Naziv predlagatelja St VINCRISTIN SULFAT 1 mg HEXAL 13,30 02.04.2007 Promed, d.o.o.,trgovanje in trženje z medicinskim A VINCRISTIN SULFAT 2 mg HEXAL 26,60 02.04.2007 Promed, d.o.o.,trgovanje in trženje z medicinskim A VINCRISTIN VIALA 2MG/2ML 12,99 01.10.2007 Salus Ljubljana, d.d., A 006980 Vinorelbin Ebewe 10 mg/ml koncentrat za raztopino za infundiranje škatla z 1 vialo z 1 ml koncentrata 26,01 27,91 03.04.2008 Ebewe Pharma Ges.m.b.H. Nfg.KG, R 007030 Vinorelbin Ebewe 10 mg/ml koncentrat za raztopino za infundiranje škatla z 1 vialo z 5 ml koncentrata 131,09 138,30 03.04.2008 Ebewe Pharma Ges.m.b.H. Nfg.KG, R 044121 VIPER VENOM ANTISERUM, EUROPEAN (equine) viala z brizgo in 2 iglama 126,54 02.04.2007 Inštitut za varovanje zdravja Republike Slovenije, A 013196 VIRACEPT 250 mg filmsko obložene tablete zloženka s plastičnim vsebnikom (z za otroke varno zaporko) z 270 tabletami 318,61 332,84 10.05.2007 ROCHE farmacevtska družba d.o.o., R VIRACEPT 250 mg filmsko obložene tablete, 300 3.000,00 02.04.2007 ROCHE farmacevtska družba d.o.o., A VIRACEPT 250 mg tablete, 270 3.000,00 02.04.2007 ROCHE farmacevtska družba d.o.o., A VIRACEPT 50 mg/g peroralni prašek, 1 3.000,00 02.04.2007 ROCHE farmacevtska družba d.o.o., A 054046 VIRACEPT peroralni prašek 50 mg/g zloženka s plastičnim vsebnikom po 144 g praška in dvema mericama (za 1 g in 5 g praška) 05.05.2006 ROCHE farmacevtska družba d.o.o., R 054038 VIRACEPT tablete 250 mg zloženka z 270 tabletami v plastičnem vsebniku 05.05.2006 ROCHE farmacevtska družba d.o.o., R 372 / 393
Javna agencija RS za zdravila in medicinske pripomočke SEZNAM CEN ZDRAVIL IN CEN ZDRAVIL NA DEBELO <strong>4.4.2008</strong> štev.: 61-22/2007-51 Delovna šifra Zaščiteno ime Proizvaj. cena Cena na Datum debelo veljavnosti Naziv predlagatelja St 091634 Virolex 200 mg tablete škatla z 20 tabletami (2 x 10 tablet v pretisnem omotu) 3,66 4,03 02.04.2007 KRKA, tovarna zdravil, d.d., Novo mesto, R 091693 Virolex 250 mg prašek za raztopino za infundiranje škatla s 5 vialami s praškom 41,09 43,80 02.04.2007 KRKA, tovarna zdravil, d.d., Novo mesto, R 091758 Virolex 30 mg/1 g mazilo za oko škatla s tubo s 4,5 g mazila 5,96 6,56 02.04.2007 KRKA, tovarna zdravil, d.d., Novo mesto, R 091669 Virolex 50 mg/1 g krema škatla s tubo s 5 g kreme 0,00 4,67 02.04.2007 KRKA, tovarna zdravil, d.d., Novo mesto, R 091189 Virolex 50 mg/1 g krema škatla s tubo z 2 g kreme 0,00 3,03 02.04.2007 KRKA, tovarna zdravil, d.d., Novo mesto, R 091812 VisiClear 0,5 mg/ml kapljice za oko, raztopina škatla s plastenko z zaporko s kapalko s 15 ml raztopine 0,00 3,10 02.04.2007 McNeil Products Limited, Foundation Park, R 487511 VISINE DRY EYES, tekoči gel, kapljice; plastenka 10 ml 3,32 02.04.2007 McNeil Products Limited, Foundation Park, A 487538 VISINE INTENSIVE, 1%, tekoči gel, kapljice; 10 vial x 0,5 ml 3,32 02.04.2007 McNeil Products Limited, Foundation Park, A 487503 VISINE TIRED EYES SENSITIVE, 0,5 %, tekoči gel, kapljice; 10 vial x 0,5 ml 3,22 02.04.2007 McNeil Products Limited, Foundation Park, A 487481 VISINE TIRED EYES, 0,5 %, tekoči gel, kapljice; plastenka 10 ml 3,22 02.04.2007 McNeil Products Limited, Foundation Park, A 023884 VISIPAQUE 150 mg I/ml zloženka z 10 plastenkami po 50 ml raztopine 0,00 150,00 02.04.2007 Higiea, d.o.o., Zastopstva in trgovina, R 023892 VISIPAQUE 150 mg I/ml zloženka z 10 stekleničkami po 50 ml raztopine 20.09.2005 Higiea, d.o.o., Zastopstva in trgovina, R 373 / 393
Page 1 and 2:
Javna agencija RS za zdravila in me
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322: Javna agencija RS za zdravila in me
Page 371: Javna agencija RS za zdravila in me
Page 393: Javna agencija RS za zdravila in me
show all

4.4.2008 - jazmp

Create successful ePaper yourself

Delete template?

Save as template?